M
Marco Salvetti
Researcher at Sapienza University of Rome
Publications - 294
Citations - 13327
Marco Salvetti is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Multiple sclerosis & Medicine. The author has an hindex of 44, co-authored 263 publications receiving 10931 citations. Previous affiliations of Marco Salvetti include Max Planck Society & Istituto Neurologico Mediterraneo.
Papers
More filters
Journal ArticleDOI
Progressive MS: from pathophysiology to drug discovery:
Marco Salvetti,Douglas Landsman,Peter Schwarz-Lam,Giancarlo Comi,Alan J. Thompson,Robert J. Fox +5 more
TL;DR: Key findings are thatcerted efforts are essential to prioritise pathogenetic mechanisms according to impact on the disease and druggability, and genome-wide association studies must try to identify variants associated with disease progression.
Journal ArticleDOI
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study.
Maria Pia Sormani,Irene Schiavetti,Doriana Landi,Luca Carmisciano,Nicola Rossi,Cinzia Cordioli,Lucia Moiola,Marta Radaelli,Paolo Immovilli,Marco Capobianco,Vincenzo Brescia Morra,Maria Trojano,Gioacchino Tedeschi,Giancarlo Comi,Giancarlo Comi,Mario Alberto Battaglia,Francesco Patti,Yara Dadalti Fragoso,Sedat Sen,Aksel Siva,Roberto Furlan,Marco Salvetti +21 more
TL;DR: The MuSC-19 project as mentioned in this paper is an Italian cohort study open to international partners that collects data on multiple sclerosis patients with COVID-19 during the second wave of the pandemic.
Journal ArticleDOI
Bacterial vaccines for the treatment of multiple sclerosis and other autoimmune diseases
Graham A. W. Rook,Giovanni Ristori,Marco Salvetti,Gavin Giovannoni,Edward J. Thompson,John Lawson Stanford +5 more
TL;DR: It is argued that blocking Th1-mediated autoimmunity by deviating the response to Th2 might prove a dangerous strategy in humans, and that the authors should distinguish between potentially pathogenic Th2 effector cells and Th2-like physiological regulators of Th1 responses.
Journal ArticleDOI
Geographic Population Structure in Epstein-Barr Virus Revealed by Comparative Genomics
Matteo Chiara,Caterina Manzari,Claudia Lionetti,Rosella Mechelli,Eleni Anastasiadou,Maria Chiara Buscarinu,Giovanni Ristori,Marco Salvetti,Ernesto Picardi,Anna Maria D'Erchia,Graziano Pesole,David S. Horner +11 more
TL;DR: A striking geographic distribution of EBV sub-populations with distinct allele frequency distributions is revealed, and mechanisms that potentially explain these observations are discussed, and their implications for understanding the association ofEBV with human disease are discussed.
Journal ArticleDOI
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group
Antonio Bertolotto,Marco Capobianco,Maria Pia Amato,Elisabetta Capello,Ruggero Capra,Diego Centonze,Maria di Ioia,Antonio Gallo,Luigi M.E. Grimaldi,Luisa Imberti,Alessandra Lugaresi,Chiara Rosa Mancinelli,Maria Giovanna Marrosu,Lucia Moiola,Enrico Montanari,Silvia Romano,Luigina Musu,Damiano Paolicelli,Francesco Patti,Carlo Pozzilli,Silvia Rossi,Marco Salvetti,G. Tedeschi,Maria Rosaria Tola,Maria Troiano,Mauro Zaffaroni,Simona Malucchi +26 more
TL;DR: In this paper, a panel of Italian neurologists from 17 MS clinics convened in Milan to review and discuss data on binding/neutralizing antibodies (NAbs) and their clinical relevance in the treatment of MS.